Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-22
1995-08-08
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483385, C07D23396, A61K 31165
Patent
active
054399270
ABSTRACT:
The .beta.-oxo-.beta.-benzenepropanethioamide derivative of the present invention has potassium channel opening action and is useful for treatment of hypertension, asthma, hypersensitive colon syndrome, and enteritis through pharmacological actions including blood vessel dilation, bronchial tract dilation, relaxation of gastrointestinal tract smooth muscle, and the like. The present invention also includes a pharmaceutical composition containing, as the active ingredient, the compound of the present invention and a method for producing the same.
REFERENCES:
patent: 5332833 (1994-07-01), Sekiya et al.
Hayashi Junko
Nagano Tatsuo
Seino Asami
Sekiya Tetsuo
Shimpuku Tetsuro
Higel Floyd D.
Mitsubishi Kasei Corporation
LandOfFree
Imidazoyl-.beta.-oxo-.beta.-benzenepropanethiomide derivative, c does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoyl-.beta.-oxo-.beta.-benzenepropanethiomide derivative, c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoyl-.beta.-oxo-.beta.-benzenepropanethiomide derivative, c will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-971473